ArticleESC heart failure2026
Characterization of incident heart failure after ischaemic stroke/transient ischaemic attack: a UK Biobank study.
Article in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionTo define incident heart failure (HF) risk in ischaemic stroke/transient ischaemic attack (TIA) survivors. The secondary aims were to define the association of HF with all-cause mortality in stroke survivors and to describe their cardiac magnetic resonance (CMR) findings.
methodsThis was a prospective cohort study using the UK Biobank (UKBB) cohort of individuals aged 40 to 69 years old. We excluded individuals with prior HF and stratified them by history of ischaemic stroke/TIA. The main outcome was incident HF as defined by hospital admissions coded for heart failure. Secondary outcomes were all-cause mortality, myocardial infarction, and CMR findings.
resultsWe included 405 406 individuals (age 56.5 years, 45.6% males). Over 13.7 years, 15 565 individuals experienced incident HF. Stroke survivors had an overall HR of 3.6 [95% confidence interval (CI) 3.3-3.8, P < .0001] for HF hospitalization and an adjusted HR of 1.4 (95% CI 1.3-1.5, P < .0001). The risk of HF hospitalization was greater than the risk of myocardial infarction (12.6% vs 5.4%). Stroke survivors with HF had a lower LVEF and higher LV mass than those without HF. Incident HF in stroke survivors was associated with a HR of 1.8 (95% CI 1.6-1.9, P < .0001) for mortality.
conclusionIncident HF is common in stroke survivors and strongly associates with mortality. The risk of HF varies greatly depending on underlying risk factors. Exploratory analyses suggest that stroke survivors with HF may have a lower ejection fraction phenotype. Future trials of HF preventive therapy in high-risk stroke survivors are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.